1
|
van der Schors T, Lozano-Blázquez A, Kuruc Poje D, Miljković N, Süle A, Kohl S. Digital health. Eur J Hosp Pharm 2024; 31:188-190. [PMID: 37657918 DOI: 10.1136/ejhpharm-2023-003918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/03/2023] Open
Affiliation(s)
| | - Ana Lozano-Blázquez
- Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - Darija Kuruc Poje
- Hospital Pharmacy, General Hospital Dr Tomislav Bardek, Koprivnica, Croatia
| | - Nenad Miljković
- Hospital Pharmacy, Institute of Orthopaedics Banjica, Belgrade, Serbia
| | - András Süle
- Department of Pharmacy, Peterfy Korhaz-Rendelointezet es Manninger Jeno Orszagos Traumatologiai Intezet, Budapest, Hungary
- European Association of Hospital Pharmacists, Brussels, Belgium
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
2
|
Kuruc Poje D, Fitzpatrick RW, Stevens C, Machin C, Underhill J, Horák P, Batista A, Süle A, Miljković N, Plesan C, Kohl S, Marzal Lopez G. Investigation of the hospital pharmacy profession in Europe. Eur J Hosp Pharm 2024:ejhpharm-2023-004066. [PMID: 38604616 DOI: 10.1136/ejhpharm-2023-004066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Accepted: 01/17/2024] [Indexed: 04/13/2024] Open
Abstract
OBJECTIVE From 1995, the European Association of Hospital Pharmacists (EAHP) has regularly investigated the progress of the hospital pharmacy profession in Europe, and identified key barriers and drivers of this. The most recent 'Investigation of the Hospital Pharmacy Profession in Europe' was conducted from November 2022 to March 2023. METHODS The online questionnaire was sent to all hospital pharmacies in EAHP member countries. The investigation was drafted using the same questions as the 2015 baseline survey. Where possible and relevant, responses were compared with the data from previous surveys that monitored the implementation of the EAHP statements. Keele University, Centre for Medicines Optimisation, School of Pharmacy and Bioengineering, UK analysed the data. RESULTS The overall number of responses was 653, with a better response rate of 19% compared with 14% in 2018 statements survey. The findings indicated that participating hospital pharmacies have similar characteristics to previous surveys. Section 1 (Introductory statements and governance), section 2 (Selection, procurement and distribution), section 3 (Production and compounding), section 5 (Patient safety and quality assurance) questions were generally answered positively, with results ranging from 52% to 90%. However, results for section 4 (Clinical pharmacy services) returned lower levels of positivity, with responses from 8 of the 15 questions being less than 60%. When asked what is preventing hospital pharmacists from achieving implementation of these activities, most answers were limited capacity, not considered to be a priority by managers, or other healthcare professionals do this. The last section focused on self-assessment and action planning, with fewer than 50% of positive responses; COVID-19 preparedness and vaccines with mixed positive and negative responses. Furthermore, implementation of the falsified medicines directive impacted the medication handling processes in 50% or more of the answers. Regarding sustainability, the majority (59%) of respondents felt a greater focus should be on sustainability from an organisational or management perspective. CONCLUSION Results offer valuable insights into the hospital pharmacy profession throughout Europe. While there have been improvements in certain areas, challenges remain, particularly in implementing clinical pharmacy services. The findings provide a foundation for further dialogue, advocacy, and strategic planning to advance the role of hospital pharmacists and enhance patient care in Europe's healthcare systems.
Collapse
Affiliation(s)
- Darija Kuruc Poje
- Hospital Pharmacy, General Hospital Dr Tomislav Bardek, Koprivnica, Europe, Croatia
- European Association of Hospital Pharmacists, Brussels, Belgium
| | - Raymond William Fitzpatrick
- Keele University, Centre for Medicines Optimisation, School of Pharmacy and Bioengineering, Staffordshire, UK
| | - Claire Stevens
- Keele University, Centre for Medicines Optimisation, School of Pharmacy and Bioengineering, Staffordshire, UK
| | - Carl Machin
- Keele University, Centre for Medicines Optimisation, School of Pharmacy and Bioengineering, Staffordshire, UK
| | - Jonathan Underhill
- Keele University, Centre for Medicines Optimisation, School of Pharmacy and Bioengineering, Staffordshire, UK
| | - Petr Horák
- Hospital Pharmacy, University Hospital Motol, Prague, Czech Republic
| | - Aida Batista
- Unidade Hospitalar do Médio Ave EPE, Santo Tirso, Porto, Portugal
| | - András Süle
- European Association of Hospital Pharmacists, Brussels, Belgium
- Department of Pharmacy, Peterfy Korhaz-Rendelointezet es Manninger Jeno Orszagos Traumatologiai Intezet, Budapest, Hungary
| | - Nenad Miljković
- European Association of Hospital Pharmacists, Brussels, Belgium
- Hospital Pharmacy, Institute of Orthopaedics Banjica, Belgrade, Serbia
| | - Claudia Plesan
- Oncology Center Drobeta Turnu Severin, Drobeta-Turnu Severin, Romania
| | - Stephanie Kohl
- European Association of Hospital Pharmacists, Brussels, Belgium
| | | |
Collapse
|
3
|
Polidori P, Makridaki D, Kohl S. Clinical trials. Eur J Hosp Pharm 2024; 31:162-164. [PMID: 36931719 PMCID: PMC10895182 DOI: 10.1136/ejhpharm-2022-003471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/19/2023] Open
Affiliation(s)
- Piera Polidori
- Hospital Pharmacy Complex Operational Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Despina Makridaki
- Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
4
|
Miljković N, Polidori P, Leonardi Vinci D, Kuruc Poje D, Makridaki D, Kohl S, Süle A. Results of EAHP's 2023 shortages survey. Eur J Hosp Pharm 2024:ejhpharm-2024-004090. [PMID: 38307707 DOI: 10.1136/ejhpharm-2024-004090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2024] [Accepted: 01/23/2024] [Indexed: 02/04/2024] Open
Abstract
AIMS AND OBJECTIVE The aim of the European Association of Hospital Pharmacists (EAHP)'s 2023 shortages survey was to collect data on causes and mitigation strategies of shortages of medicines and medical devices and their impact on patient care. The survey targeted hospital pharmacists (HPs), physicians (PHYs), nurses (NRS) and other healthcare professionals (OHCPs). A separate set of questions addressed patients (PTNs). METHODS A 49-question survey was carried out by a team at EAHP, collecting information from European HPs, PTNs, NRS, PHYs and OTHCs on shortages of medicines and medical devices in their respective countries. The survey ran from 27 February to 19 May 2023. The results were analysed by EAHP. RESULTS There were 1497 HP responses to the 2023 survey. While 95% (n=1429) of HPs and 86% (n=127) of OHCPs consider medicine shortages an ongoing problem, 84% (n=48) of PHYs and 68% (n=15) of NRS also agreed. Shortages of active pharmaceutical ingredients (77%, n=1148), manufacturing (67%, n=1007) and supply chain problems (50%, n=752) are major causes of shortages according to HPs as well as NRS and OHCPs; PHYs (49%, n=18) consider pricing to be the driver. More than 60% (n=765) of HPs, 55% (n=11) of NRS, 57% (n=30) of PHYs and 46% (n=56) of OHCPs experienced shortages of medical devices in 2022. Antimicrobials were most affected, according to all respondent groups, followed by analgesics, anaesthetics, cardiovascular and paediatric medicines. HPs (59%, n=269), NRS (57%, n=4), OHCPs (56%, n=37) and PHYs (54%, n=14) consider delays in care as the main consequence of medication shortages. CONCLUSIONS Shortages of medicines and medical devices affect healthcare services and patient care. Increased transparency and access to information regarding ongoing and emerging shortages as well as better preparedness of healthcare professionals is crucial to their effective management.
Collapse
Affiliation(s)
- Nenad Miljković
- Hospital Pharmacy, Institute of Orthopaedics Banjica, Belgrade, Serbia
- European Association of Hospital Pharmacists, Brussels, Belgium
| | - Piera Polidori
- Hospital Pharmacy, The joined hospitals Villa Sofia-Cervello, Palermo, Italy
| | | | - Darija Kuruc Poje
- Hospital Pharmacy, General Hospital "Dr Tomislav Bardek", Koprivnica, Croatia
| | - Despina Makridaki
- Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
| | - Stephanie Kohl
- Policy and Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| | - András Süle
- European Association of Hospital Pharmacists, Brussels, Belgium
- Hospital Pharmacy, Péterfy Hospital, Budapest, Hungary
| |
Collapse
|
5
|
Lozano-Blázquez A, Makridaki D, Plesan CR, Kohl S. Advanced therapy medicinal products. Eur J Hosp Pharm 2023; 31:63-65. [PMID: 36931720 PMCID: PMC10800277 DOI: 10.1136/ejhpharm-2022-003470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/19/2023] Open
Affiliation(s)
- Ana Lozano-Blázquez
- Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - Despina Makridaki
- Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
| | | | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
6
|
Kohaut J, Fischer-Mertens J, Cernaianu G, Schulten D, Holtkamp G, Kohl S, Habbig S, Klein R, Kribs A, Gottschalk I, Berg C, Dübbers M. Postnatal surgical treatment and complications following intrauterine vesicoamniotic shunting with the SOMATEX® intrauterine shunt. A single center experience. J Pediatr Urol 2023; 19:567.e1-567.e6. [PMID: 37451915 DOI: 10.1016/j.jpurol.2023.06.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 06/23/2023] [Accepted: 06/28/2023] [Indexed: 07/18/2023]
Abstract
INTRODUCTION Intrauterine vesicoamniotic shunting (VAS) using a Somatex® shunt was shown to significantly affect survival of male fetuses with megacystis in suspected lower urinary tract obstruction (LUTO) [Figure 1]. Data on postnatal surgical management and complications are largely lacking. OBJECTIVE To describe the postnatal management of patients with prenatal VAS for megacystitis in suspected severe LUTO. STUDY DESIGN All male newborns with previous intrauterine VAS using a Somatex® shunt treated in our institution were retrospectively analyzed. We evaluated the spectrum of urethral pathologies and postnatal surgical management, especially focusing on shunt removal. RESULTS Between 2016 and 2022, 17 patients (all male) were treated postnatally in our institution after VAS for suspected severe LUTO. Five fetuses with dislocated shunts underwent re-implantation in utero. Overall, premature birth before the 38th week of gestation was observed in eight patients (8/17). Seven shunts could be removed without further anesthesia as a bedside procedure. Ten patients required surgical shunt removal under general anesthesia due to migration (59%). Laparoscopic shunt extraction was performed in 8/10 cases. Most frequently, dislocated shunts were located incorporated in the detrusor in eight cases and the removal required a bladder suture in 2/8 patients. In one case, the shunt was removed from the abdominal wall and in one case from the intestine wall [Figure 2]. Posterior urethral valves were found in 8/17 patients, 6/17 patients showed a urethral atresia and one patient had urethral duplication. In two patients, we identified a high grade bilateral vesicoureteral reflux without LUTO. CONCLUSION In our observation, more than half of the newborns with megacystis in suspected LUTO require a shunt removal surgery after early VAS using a Somatex® shunt. Urethral atresia may be found more frequently in these patients. These data should be taken into consideration for prenatal counselling of parents and planning of postnatal management.
Collapse
Affiliation(s)
- J Kohaut
- Division of Pediatric Surgery, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
| | - J Fischer-Mertens
- Division of Pediatric Surgery, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - G Cernaianu
- Division of Pediatric Surgery, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - D Schulten
- Division of Pediatric Surgery, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - G Holtkamp
- Division of Pediatric Surgery, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - S Kohl
- Department of Pediatrics and Adolescent Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - S Habbig
- Department of Pediatrics and Adolescent Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - R Klein
- Department of Pediatrics and Adolescent Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - A Kribs
- Department of Pediatrics and Adolescent Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - I Gottschalk
- Division of Prenatal Medicine, Gynecological Ultrasound and Fetal Surgery, Department of Obstetrics and Gynecology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - C Berg
- Division of Prenatal Medicine, Gynecological Ultrasound and Fetal Surgery, Department of Obstetrics and Gynecology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
| | - M Dübbers
- Division of Pediatric Surgery, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
| |
Collapse
|
7
|
Horák P, Makridaki D, Polidori P, Süle A, Bertin L, Kohl S. Hospital pharmacy workforce. Eur J Hosp Pharm 2023:ejhpharm-2023-003919. [PMID: 37696590 DOI: 10.1136/ejhpharm-2023-003919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/13/2023] Open
Affiliation(s)
- Petr Horák
- Hospital Pharmacy, University Hospital Motol, Prague, Czech Republic
| | - Despina Makridaki
- Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
| | - Piera Polidori
- Hospital Pharmacy Complex Operational Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - András Süle
- Department of Pharmacy, Peterfy Korhaz-Rendelointezet es Manninger Jeno Orszagos Traumatologiai Intezet, Budapest, Hungary
- European Association of Hospital Pharmacists, Brussels, Belgium
| | - Louis Bertin
- Hospital Pharmacy Complex, Centre Hospitalier de l'Arrondissement de Montreuil/mer, Montreuil/mer, France
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
8
|
Kuruc Poje D, Miljković N, Polidori P, Kohl S. Infectious diseases and antimicrobial resistance. Eur J Hosp Pharm 2023:ejhpharm-2023-003920. [PMID: 37657919 DOI: 10.1136/ejhpharm-2023-003920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/03/2023] Open
Affiliation(s)
- Darija Kuruc Poje
- Hospital Pharmacy, General Hospital Dr Tomislav Bardek, Koprivnica, Croatia
| | - Nenad Miljković
- Hospital Pharmacy, Institute of Orthopaedics Banjica, Belgrade, Serbia
| | - Piera Polidori
- Hospital Pharmacy Complex Operational Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
9
|
Miljković N, Makridaki D, Kohl S. Access to medicines. Eur J Hosp Pharm 2023; 30:257-260. [PMID: 34949652 PMCID: PMC10447961 DOI: 10.1136/ejhpharm-2021-002974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Nenad Miljković
- Hospital Pharmacy, Institute of Orthopaedic Surgery "Banjica", Belgrade, Serbia
| | - Despina Makridaki
- Pharmacy Services, Sismanoglio-Amalia Fleming, General Hospital of Attica, Athens, Greece
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
10
|
Batista A, Makridaki D, van der Schors T, Kohl S. Hazardous medicinal products. Eur J Hosp Pharm 2023; 30:261-263. [PMID: 36922005 PMCID: PMC10447955 DOI: 10.1136/ejhpharm-2022-003472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/17/2023] Open
Affiliation(s)
- Aida Batista
- Pharmacy, Centro Hospitalar do Médio Ave EPE, Santo Tirso, Portugal
| | - Despina Makridaki
- Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
| | | | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
11
|
Kohl S. Hospital pharmacists' first impressions on the revision of the General Pharmaceutical Legislation. Eur J Hosp Pharm 2023; 30:247-248. [PMID: 37348910 PMCID: PMC10359799 DOI: 10.1136/ejhpharm-2023-003862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/24/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1000, Belgium
| |
Collapse
|
12
|
Kohl S. EMA guidance for industry to prevent and mitigate medicine shortages. Eur J Hosp Pharm 2023; 30:245-246. [PMID: 37348909 PMCID: PMC10359800 DOI: 10.1136/ejhpharm-2023-003861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/24/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, 1200, Belgium
| |
Collapse
|
13
|
Kohl S. EAHP sets out to future-proof the hospital pharmacy workforce. Eur J Hosp Pharm 2023; 30:185-186. [PMID: 37085176 PMCID: PMC10176988 DOI: 10.1136/ejhpharm-2023-003789] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/23/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
14
|
Kohl S. Council of Europe - recommendation on access to medicines and devices. Eur J Hosp Pharm 2023; 30:183-184. [PMID: 37085177 PMCID: PMC10176989 DOI: 10.1136/ejhpharm-2023-003788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/23/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
15
|
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
16
|
Kohl S. European Commission taking action to mitigate risks of device shortages. Eur J Hosp Pharm 2023; 30:120-122. [PMID: 36810346 PMCID: PMC9986925 DOI: 10.1136/ejhpharm-2023-003716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
17
|
Kohl S. Digital medication management in healthcare settings. Eur J Hosp Pharm 2023; 30:61-62. [PMID: 36535693 PMCID: PMC9811528 DOI: 10.1136/ejhpharm-2022-003641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
18
|
Affiliation(s)
- András Süle
- Department of Pharmacy, Péterfy Hospital - National Institute of Traumatology, Budapest, Hungary
| | - Petr Horák
- Hospital Pharmacy, Motol University Hospital, Prague, Czech Republic
| | - Despina Makridaki
- Pharmacy, 'Sismanoglio- Amalia Fleming', General Hospital of Attica, Athens, Greece
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
19
|
Kohl S. Help EAHP assess and advance hospital pharmacy! Eur J Hosp Pharm 2023; 30:60. [PMID: 36535692 PMCID: PMC9811582 DOI: 10.1136/ejhpharm-2022-003640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
20
|
Kohl S. EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU. Eur J Hosp Pharm 2022; 29:363. [PMID: 36283720 PMCID: PMC9614114 DOI: 10.1136/ejhpharm-2022-003571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
21
|
Kohl S. EAHP general assembly updates position paper on clinical trials. Eur J Hosp Pharm 2022; 29:362-363. [PMID: 36283721 PMCID: PMC9614123 DOI: 10.1136/ejhpharm-2022-003572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
22
|
Kohl S. Roberto Frontini appointed as a member of PRAC. Eur J Hosp Pharm 2022; 29:239-240. [DOI: 10.1136/ejhpharm-2022-003412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
23
|
Kohl S. European health data space proposal launched. Eur J Hosp Pharm 2022; 29:240. [DOI: 10.1136/ejhpharm-2022-003413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
24
|
Kohl S. Role of EMA for crises strengthened. Eur J Hosp Pharm 2022; 29:176-177. [PMID: 35459698 PMCID: PMC9047919 DOI: 10.1136/ejhpharm-2022-003341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
25
|
Kohl S. Results of EAHP's ePI survey released. Eur J Hosp Pharm 2022; 29:177-178. [PMID: 35459699 PMCID: PMC9047931 DOI: 10.1136/ejhpharm-2022-003340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
26
|
Kohl S. Medical device resources for hospital pharmacists. Eur J Hosp Pharm 2022; 29:118. [PMID: 35190456 PMCID: PMC8899629 DOI: 10.1136/ejhpharm-2022-003256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
27
|
Kohl S. European Commission publishes study on shortages of medicines. Eur J Hosp Pharm 2022; 29:116-118. [PMID: 35190455 PMCID: PMC8899647 DOI: 10.1136/ejhpharm-2022-003255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
28
|
Miljković N, Polidori P, Kohl S. Managing antibiotic shortages: lessons from EAHP and ECDC surveys. Eur J Hosp Pharm 2022; 29:90-94. [PMID: 35190453 PMCID: PMC8899686 DOI: 10.1136/ejhpharm-2021-003110] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2021] [Accepted: 11/30/2021] [Indexed: 11/04/2022] Open
Abstract
AIMS AND OBJECTIVE To compare antibiotic shortages in Europe between 2013 and 2020 and the views of hospital pharmacists on overcoming shortages via antimicrobial stewardship. METHODS A series of European Association of Hospital Pharmacists (EAHP) surveys on medicine shortages, including a survey on the future crisis preparedness of hospital pharmacies, conducted between 2013 and 2020 were compared for the type of antibiotic shortages and respective mitigation strategy. These were analysed taking into account hospital pharmacists' views on antibiotics provided in the European Centre for Disease Prevention and Control (ECDC) survey on healthcare professionals' knowledge, attitudes and behaviours about antibiotics, antibiotic use and antibiotic resistance from 2018. RESULTS Since 2013 there has frequently been a shortage of antibiotics in European hospitals. In 2014, 67% (347/521) of hospital pharmacists experienced shortages of antimicrobials compared with 77% (1032/1348) in 2018, 63% (1158/1837) in 2019 and 37% (539/1466) in 2020. More than 80% of hospital pharmacists managed antibiotic shortages through substitution in 2014 (284/336) and 2018 (786/946), while this percentage was 40% (63/158) and 42% (620/1466) in 2019 and 2020, respectively. Although 72% (870/1204) of hospital pharmacists received information on how to avoid inappropriate antibiotic prescribing, dispensing and administration, only 37% (450/1204) changed their views and 28% (338/1204) changed their practice in steering antimicrobial treatment. CONCLUSION Antibiotic shortages affect proper antimicrobial stewardship because of limited appropriate alternatives, taking into account patients' clinical condition and type of infection. While substitution remains a leading mitigating tool for antibiotic shortages, it carries numerous risks and the potential for antimicrobial resistance and suboptimal health outcomes.
Collapse
Affiliation(s)
- Nenad Miljković
- Hospital Pharmacy, Institute of Orthopaedics Banjica, Belgrade, Serbia
| | - Piera Polidori
- Hospital Pharmacy, United Villa Solfia-Cervello Hospitals, Palermo, Sicily, Italy
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
29
|
Gutmann S, Tästensen C, Böttcher IC, Dietzel J, Loderstedt S, Kohl S, Matiasek K, Flegel T. Clinical use of a new frameless optical neuronavigation system for brain biopsies: 10 cases (2013-2020). J Small Anim Pract 2022; 63:468-481. [PMID: 35141897 DOI: 10.1111/jsap.13482] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 11/09/2021] [Accepted: 01/18/2022] [Indexed: 01/25/2023]
Abstract
OBJECTIVES The aim of the retrospective study was to describe the brain biopsy procedure using a new frameless optical neuronavigation system and to report diagnostic yield and complications associated with the procedure. MATERIALS AND METHODS The medical records for all dogs with forebrain lesions that underwent brain biopsy with a frameless optical neuronavigation system in a single referral hospital between 2013 and 2020 were retrospectively analysed. Following data were collected: signalment, neurological signs, diagnostic findings, number of brain biopsy samples, sampled region, complications, duration of hospitalisation, whether the samples were diagnostic and histopathological diagnoses. The device consists of a computer workstation with navigation software, an infrared camera, patient tracker and reflective instruments. The biopsy needle was equipped with reflective spheres, so the surgeon could see the position of the needle during sampling the intracranial lesion free handed through a mini-burr hole. RESULTS Ten dogs were included. Absolute diagnostic yield based on specific histopathological diagnosis was 73.9%. Three dogs had immune-mediated necrotizing encephalitis, two dogs showed a necrotizing leukoencephalitis and two dogs a meningoencephalitis of unknown origin. In two dogs, the brain specimen showed unspecific changes. In one dog, the samples were non-diagnostic. Seven dogs showed no neurological deterioration, one dog mild temporary ataxia and two dogs died within 36 hours post brain biopsy. CLINICAL SIGNIFICANCE In these 10 dogs, the frameless optical neuronavigation system employed was useful to gain diagnostic brain biopsy samples. Considering the mortality rate observed, further studies are needed to confirm the safety of this procedure and prove its actual clinical effectiveness.
Collapse
Affiliation(s)
- S Gutmann
- Department for Small Animal, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany
| | - C Tästensen
- Department for Small Animal, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany
| | - I C Böttcher
- Department for Small Animal, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany
| | - J Dietzel
- Department for Small Animal, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany
| | - S Loderstedt
- Department for Small Animal, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany
| | - S Kohl
- Department for Small Animal, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany
| | - K Matiasek
- Section of Clinical and Comparative Neuropathology, Ludwig-Maximilians-Universität, Munich, Germany
| | - T Flegel
- Department for Small Animal, Faculty of Veterinary Medicine, Leipzig University, 04103, Leipzig, Germany
| |
Collapse
|
30
|
Kohl S. Oath to Society - EAHP and ESCP show the public what clinical and hospital pharmacists are all about. Eur J Hosp Pharm 2022; 29:60-61. [PMID: 34930795 PMCID: PMC8717773 DOI: 10.1136/ejhpharm-2021-003167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
31
|
Kohl S. Show how you keep antibiotics working during this year's EAAD. Eur J Hosp Pharm 2022; 29:61-62. [PMID: 34930796 PMCID: PMC8717794 DOI: 10.1136/ejhpharm-2021-003168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
32
|
Kohl S. EAHP's survey on hazardous medicinal products. Eur J Hosp Pharm 2021; 28:356. [PMID: 34697052 DOI: 10.1136/ejhpharm-2021-003093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
33
|
Kohl S. Spread awareness, stop resistance - getting ready for WAAW and EAAD. Eur J Hosp Pharm 2021; 28:357-358. [PMID: 34697053 DOI: 10.1136/ejhpharm-2021-003094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
34
|
Leonardi Vinci D, Polidori P, Miljković N, Batista A, Amann S, Makridaki D, Kohl S. Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies. Eur J Hosp Pharm 2021; 29:242-247. [PMID: 34497129 PMCID: PMC8440123 DOI: 10.1136/ejhpharm-2021-002944] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2021] [Accepted: 08/03/2021] [Indexed: 12/22/2022] Open
Abstract
Aim The present survey aimed to collect information on the lessons learnt from the COVID-19 pandemic by hospital pharmacists. It focused on the shortages of health goods and the experiences of hospitals during the first phase of the crisis. Methods A 17-question survey was conducted by EAHP, looking at the experiences of hospital pharmacists during the COVD-19 pandemic. The survey ran from 16 September to 23 December 2020. Statistical analysis included backward stepwise logistic regression (BSLR), Pearson’s χ2 test, t-test and one-way ANOVA, as appropriate; p≤0.05 was considered statistically significant. Results 1466 hospital pharmacists answered the survey fully. 58%, 63% and 69% of them experienced shortages in medicines, disinfectants and personal protective equipment (PPE), respectively. BSLR showed that being a COVID-19 dedicated hospital increased the risk of medicine shortages (OR 1.63, 95% CI 1.15 to 2.31) but the shortages of disinfectants and PPE were lower (OR 0.62, 95% CI 0.44 to 0.88; OR 0.60, 95% CI 0.42 to 0.85). Being a specialised hospital reduced the odds of medicine shortages (OR 0.59, 95% CI 0.40 to 0.88), while countries with a greater percentage of the population infected had increased odds for all three types of shortages (OR 1.16, 95% CI 1.01 to 1.23; OR 1.34, 95% CI 1.19 to 1.50; OR 1.21, 95% CI 1.09 to 1.35). The odds were also higher in answers submitted in September compared with December. The classes of medicines with highest reported shortages were anaesthetics, antibiotics and muscle relaxants. The main entities that provided support were the national competent authorities and manufacturers. Conclusion Medicine shortages affected the work of hospital pharmacists during the early stages of the pandemic. The features of the crisis and the feedback described in this survey can provide interesting insights for a more resilient healthcare framework in the future.
Collapse
Affiliation(s)
| | - Piera Polidori
- Clinical Pharmacy, Institute Mediterranean per i Trapianti e Terapie ad Alta Specializzazione, Hospital Pharmacy Via Ernesto Tricomi, Palermo, Italy
| | - Nenad Miljković
- Hospital Pharmacy, Institute of Orthopaedics Banjica, Hospital Pharmacy, Belgrade, Serbia
| | - Aida Batista
- Pharmacy, Centro Hospitalar Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal
| | - Steffen Amann
- Krankenhausapotheke (Hospital Pharmacy), Muenchen Klinik gGmbH, Munchen, Germany
| | - Despina Makridaki
- Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
| | - Stephanie Kohl
- European Association of Hospital Pharmacists, 1200 Brussels, Belgium
| |
Collapse
|
35
|
Kohl S. EAHP's new President András Süle starts his term together with eight newly elected Board members. Eur J Hosp Pharm 2021; 28:293-295. [PMID: 34426484 DOI: 10.1136/ejhpharm-2021-002991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
36
|
Kohl S. Patients perspectives on drug shortages. Eur J Hosp Pharm 2021; 28:296-298. [PMID: 34426485 DOI: 10.1136/ejhpharm-2021-002990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
37
|
Kohl S. Join us in Vienna to celebrate EAHP's 25th Anniversary Congress in March 2021. Eur J Hosp Pharm 2021; 27:315. [PMID: 32839268 DOI: 10.1136/ejhpharm-2020-002474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
38
|
Kohl S. EAHP's 50th General Assembly designates András Süle as President-Elect. Eur J Hosp Pharm 2021; 27:371-372. [PMID: 33097623 DOI: 10.1136/ejhpharm-2020-002547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
39
|
Kohl S. European Parliament adopts report on medicines shortages. Eur J Hosp Pharm 2021; 27:372-374. [PMID: 33097624 DOI: 10.1136/ejhpharm-2020-002548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
40
|
Kohl S. ECDC report on the responses in the EU/EEA to hepatitis B and C. Eur J Hosp Pharm 2021; 27:244-247. [PMID: 32587086 DOI: 10.1136/ejhpharm-2020-002400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
41
|
van der Schors T, Amann S, Makridaki D, Kohl S. Pharmacy preparations and compounding. Eur J Hosp Pharm 2021; 28:190-192. [PMID: 33239281 PMCID: PMC8239274 DOI: 10.1136/ejhpharm-2020-002559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
| | - Steffen Amann
- Krankenhausapotheke (Hospital Pharmacy), München Klinik gGmbH, Munich, Germany
| | - Despoina Makridaki
- Pharmacy Services, "Sismanoglio- Amalia Fleming", General Hospital of Attica, Athens, Greece
| | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
42
|
Kohl S. EAHP's needs assessment survey. Eur J Hosp Pharm 2021; 28:239. [PMID: 34162677 DOI: 10.1136/ejhpharm-2021-002923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
43
|
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
44
|
Kohl S. The European coalition for vaccination calls on healthcare professionals to get vaccinated against COVID-19. Eur J Hosp Pharm 2021. [PMCID: PMC8077609 DOI: 10.1136/ejhpharm-2021-002830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
45
|
Kohl S. EAHP opinion focusing on the application of the medical device regulations. Eur J Hosp Pharm 2021. [DOI: 10.1136/ejhpharm-2021-002831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
46
|
Kohl S, Eifler L. [A 15-year-old girl with swollen and reddened toes]. Monatsschr Kinderheilkd 2021; 170:105-109. [PMID: 33903780 PMCID: PMC8059425 DOI: 10.1007/s00112-021-01190-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/26/2021] [Indexed: 11/27/2022]
Affiliation(s)
- S. Kohl
- Medizinische Fakultät und Uniklinik Köln, Klinik und Poliklinik für Kinder- und Jugendmedizin, Universität zu Köln, Kerpener Str. 62, 50937 Köln, Deutschland
| | - L. Eifler
- Medizinische Fakultät und Uniklinik Köln, Klinik und Poliklinik für Kinder- und Jugendmedizin, Universität zu Köln, Kerpener Str. 62, 50937 Köln, Deutschland
| |
Collapse
|
47
|
Kohl S. EAHP opinion on COVID-19 vaccine programmes and their implementation. Eur J Hosp Pharm 2021; 28:118-119. [PMID: 33608443 PMCID: PMC7907689 DOI: 10.1136/ejhpharm-2021-002724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
48
|
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|
49
|
Batista A, Polidori P, Kohl S. Position paper on patient safety. Eur J Hosp Pharm 2020; 28:ejhpharm-2019-001924. [PMID: 33355293 PMCID: PMC8077631 DOI: 10.1136/ejhpharm-2019-001924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Aida Batista
- Pharmacy, Centro Hospitalar Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal
| | | | - Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium
| |
Collapse
|
50
|
Kohl S. Position paper on pharmacy preparations and compounding. Eur J Hosp Pharm 2020; 28:53. [PMID: 33355285 DOI: 10.1136/ejhpharm-2020-002628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Affiliation(s)
- Stephanie Kohl
- Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
| |
Collapse
|